KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to -$3.0 million.

  • Zimmer Biomet Holdings' Change in Receivables fell 11003.34% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.2 million, marking a year-over-year decrease of 3934.88%. This contributed to the annual value of $89.7 million for FY2024, which is 7283.24% up from last year.
  • As of Q3 2025, Zimmer Biomet Holdings' Change in Receivables stood at -$3.0 million, which was down 11003.34% from -$200000.0 recorded in Q2 2025.
  • Zimmer Biomet Holdings' Change in Receivables' 5-year high stood at $70.2 million during Q4 2022, with a 5-year trough of -$34.8 million in Q1 2021.
  • Its 5-year average for Change in Receivables is $20.1 million, with a median of $18.8 million in 2025.
  • Its Change in Receivables has fluctuated over the past 5 years, first skyrocketed by 115769.23% in 2022, then tumbled by 218333.33% in 2024.
  • Quarter analysis of 5 years shows Zimmer Biomet Holdings' Change in Receivables stood at $38.8 million in 2021, then soared by 80.93% to $70.2 million in 2022, then dropped by 3.99% to $67.4 million in 2023, then dropped by 26.41% to $49.6 million in 2024, then plummeted by 106.05% to -$3.0 million in 2025.
  • Its Change in Receivables stands at -$3.0 million for Q3 2025, versus -$200000.0 for Q2 2025 and $18.8 million for Q1 2025.